Correction to: Access to the CNS: Biomarker Strategies for Dopaminergic Treatments (Pharmaceutical Research, (2018), 35, 3, (64), 10.1007/s11095-017-2333-x)

Willem Johan van den Brink; Semra Palic; Isabelle Kohler; Elizabeth Cunera Maria de Lange

doi:10.1007/s11095-018-2388-3

Correction to: Access to the CNS: Biomarker Strategies for Dopaminergic Treatments (Pharmaceutical Research, (2018), 35, 3, (64), 10.1007/s11095-017-2333-x)

Willem Johan van den Brink, Semra Palic, Isabelle Kohler, Elizabeth Cunera Maria de Lange^*

^*Corresponding author for this work

Research output: Contribution to Journal › Comment / Letter to the editor › Academic

Abstract

The third author’s name was mistakenly published with an umlaut (Isabelle Köhler). The correct spelling is “Isabelle Kohler”.

Original language	English
Article number	102
Journal	Pharmaceutical research
Volume	35
Issue number	5
DOIs	https://doi.org/10.1007/s11095-018-2388-3
Publication status	Published - 1 May 2018
Externally published	Yes

Access to Document

10.1007/s11095-018-2388-3

Persistent URL (handle)

Persistent link

Cite this

@article{61e8dfc98b5f452a9ca0c47d7068a03d,

title = "Correction to: Access to the CNS: Biomarker Strategies for Dopaminergic Treatments (Pharmaceutical Research, (2018), 35, 3, (64), 10.1007/s11095-017-2333-x)",

abstract = "The third author{\textquoteright}s name was mistakenly published with an umlaut (Isabelle K{\"o}hler). The correct spelling is “Isabelle Kohler”.",

author = "{van den Brink}, {Willem Johan} and Semra Palic and Isabelle Kohler and {de Lange}, {Elizabeth Cunera Maria}",

year = "2018",

month = may,

day = "1",

doi = "10.1007/s11095-018-2388-3",

language = "English",

volume = "35",

journal = "Pharmaceutical research",

issn = "0724-8741",

publisher = "Springer",

number = "5",

}

Correction to: Access to the CNS: Biomarker Strategies for Dopaminergic Treatments (Pharmaceutical Research, (2018), 35, 3, (64), 10.1007/s11095-017-2333-x). / van den Brink, Willem Johan; Palic, Semra; Kohler, Isabelle et al.
In: Pharmaceutical research, Vol. 35, No. 5, 102, 01.05.2018.

Research output: Contribution to Journal › Comment / Letter to the editor › Academic

TY - JOUR

T1 - Correction to

T2 - Access to the CNS: Biomarker Strategies for Dopaminergic Treatments (Pharmaceutical Research, (2018), 35, 3, (64), 10.1007/s11095-017-2333-x)

AU - van den Brink, Willem Johan

AU - Palic, Semra

AU - Kohler, Isabelle

AU - de Lange, Elizabeth Cunera Maria

PY - 2018/5/1

Y1 - 2018/5/1

N2 - The third author’s name was mistakenly published with an umlaut (Isabelle Köhler). The correct spelling is “Isabelle Kohler”.

AB - The third author’s name was mistakenly published with an umlaut (Isabelle Köhler). The correct spelling is “Isabelle Kohler”.

UR - http://www.scopus.com/inward/record.url?scp=85044337681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044337681&partnerID=8YFLogxK

U2 - 10.1007/s11095-018-2388-3

DO - 10.1007/s11095-018-2388-3

M3 - Comment / Letter to the editor

C2 - 29556786

AN - SCOPUS:85044337681

SN - 0724-8741

VL - 35

JO - Pharmaceutical research

JF - Pharmaceutical research

IS - 5

M1 - 102

ER -

Correction to: Access to the CNS: Biomarker Strategies for Dopaminergic Treatments (Pharmaceutical Research, (2018), 35, 3, (64), 10.1007/s11095-017-2333-x)

Abstract

Access to Document

Persistent URL (handle)

Other files and links

Fingerprint

Cite this